8 Coupons
�we have waited a long time and we cannot possibly wait any longer,� karmenu vella, european commissioner for environment, told the guardian. .
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the . . .
the statistics i�m quoting reveal a problem on the level of a tsunami sweeping across the whole of america and europe. .
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done. .
shocking figures uncovered by labour show some patients are suffering agonising waits of as many as 541 days to begin treatment .
'cut short' by james taylor is published on june 1 by white owl books, price ?20.